These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10557569)

  • 61. Alzheimer's disease.
    Kennedy-Malone LM; Fletcher K
    Lippincotts Prim Care Pract; 1999; 3(2):163-8. PubMed ID: 10426059
    [No Abstract]   [Full Text] [Related]  

  • 62. [A gleam of hope for Alzheimer patients?].
    Heinzl S
    Med Monatsschr Pharm; 1994 Jun; 17(6):163. PubMed ID: 8052165
    [No Abstract]   [Full Text] [Related]  

  • 63. Assessment of the value of therapeutic monitoring of tacrine in Alzheimer's disease.
    Roberts CJ; Ford JM; Truman CA; Scott M; Mäkelä PM; Wilcock GK
    Eur J Clin Pharmacol; 1998; 54(9-10):721-4. PubMed ID: 9923574
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Oral tetrahydroaminoacridine in the treatment of senile dementia, Alzheimer's type.
    N Engl J Med; 1987 Jun; 316(25):1603-5. PubMed ID: 3587295
    [No Abstract]   [Full Text] [Related]  

  • 65. Effect of tacrine in Alzheimer's disease: or non-effect?
    Talmont DM; Bowden M
    Med J Aust; 1995 Jan; 162(1):52-3. PubMed ID: 7710524
    [No Abstract]   [Full Text] [Related]  

  • 66. Alzheimer's disease: how to give and monitor tacrine therapy.
    Woo JK; Lantz MS
    Geriatrics; 1995 May; 50(5):50-3. PubMed ID: 7737527
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of tacrine in Alzheimer's disease: or non-effect?
    Broe GA; Creasey H
    Med J Aust; 1994 Sep; 161(6):348-9. PubMed ID: 8090107
    [No Abstract]   [Full Text] [Related]  

  • 68. Tacrine and lecithin in Alzheimer's disease. Tacrine is safe and effective.
    Pendlebury WW; Solomon PR
    BMJ; 1994 Jun; 308(6942):1506; author reply 1507. PubMed ID: 8019290
    [No Abstract]   [Full Text] [Related]  

  • 69. Long-term tacrine treatment effects.
    Knopman D; Schneider L; Davis K; Gracon S; Smith F
    Neurology; 1998 Feb; 50(2):567-8. PubMed ID: 9484404
    [No Abstract]   [Full Text] [Related]  

  • 70. Tacrine granted marketing approval for Alzheimer's disease.
    Clin Pharm; 1993 Dec; 12(12):873, 876. PubMed ID: 8137602
    [No Abstract]   [Full Text] [Related]  

  • 71. Tacrine-NO donor and tacrine-ferulic acid hybrid molecules as new anti-Alzheimer agents: hepatotoxicity and influence on the cytochrome P450 system in comparison to tacrine.
    Lupp A; Appenroth D; Fang L; Decker M; Lehmann J; Fleck C
    Arzneimittelforschung; 2010; 60(5):229-37. PubMed ID: 20533758
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Tacrine-induced liver damage: an analysis of 19 candidate genes.
    Alfirevic A; Mills T; Carr D; Barratt BJ; Jawaid A; Sherwood J; Smith JC; Tugwood J; Hartkoorn R; Owen A; Park KB; Pirmohamed M
    Pharmacogenet Genomics; 2007 Dec; 17(12):1091-100. PubMed ID: 18004213
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Tacrine study shows benefits, high level of intolerance at high doses.
    Am J Hosp Pharm; 1994 Jul; 51(14):1762-3. PubMed ID: 7942902
    [No Abstract]   [Full Text] [Related]  

  • 74. Tacrine for Alzheimer's disease: why is it not available on prescription to UK sufferers?
    Wilcock G
    Age Ageing; 1994 Sep; 23(5):353-5. PubMed ID: 7825478
    [No Abstract]   [Full Text] [Related]  

  • 75. Tacrine and lecithin in Alzheimer's disease. Serum tacrine concentrations too low.
    Roberts C; Mäkelä P; Ford J; Truman C
    BMJ; 1994 Jun; 308(6942):1506; author reply 1507. PubMed ID: 8019289
    [No Abstract]   [Full Text] [Related]  

  • 76. Tacrine in Alzheimer's disease.
    Lachs M
    N Engl J Med; 1993 Mar; 328(11):809-10. PubMed ID: 8437606
    [No Abstract]   [Full Text] [Related]  

  • 77. Pharmacology of Alzheimer's disease: appraisal and prospects.
    Sellal F; Nieoullon A; Michel G; Michel BF; Lacomblez L; Geerts H; Delini Stula A; Bordet R; Bentué-Ferrer D; Allain H
    Dement Geriatr Cogn Disord; 2005; 19(5-6):229-45. PubMed ID: 15767760
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Drug therapy of Alzheimer's disease. General concepts on nootropic drugs].
    Otomo E
    Nihon Rinsho; 1988 Jul; 46(7):1569-74. PubMed ID: 3221464
    [No Abstract]   [Full Text] [Related]  

  • 79. Neurology "with the bark off": tacrine, nursing home residents, and health services research.
    Phillips CD; Knopman DS
    Neurology; 1999 Jan; 52(2):227-30. PubMed ID: 9932935
    [No Abstract]   [Full Text] [Related]  

  • 80. Tacrine and lecithin in Alzheimer's disease. Patient heterogeneity explains varied response.
    Levy R
    BMJ; 1994 Jun; 308(6942):1506; author reply 1507. PubMed ID: 8019288
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.